000 03648nam a22004575i 4500
999 _c200457004
_d75216
003 DE-He213
005 20231109085737.0
007 cr nn 008mamaa
008 221018s2022 sz | s |||| 0|eng d
020 _a9783031108396
024 7 _a10.1007/978-3-031-10839-6
_2doi
040 _aTR-AnTOB
_beng
_cTR-AnTOB
_erda
060 0 0 _aQZ 267
072 7 _aMJCL
_2bicssc
072 7 _aMED062000
_2bisacsh
072 7 _aMJCL
_2thema
096 _aQZ267EBK
100 1 _aLima Cavalcanti, Iago Dillion.
_eauthor.
_0(orcid)0000-0001-6625-8395
_4aut
_4http://id.loc.gov/vocabulary/relators/aut
245 1 0 _aChemotherapy Protocols and Infusion Sequence
_h[electronic resource] :
_bSchedule Consideration in Cancer Treatment /
_cby Iago Dillion Lima Cavalcanti.
250 _a1st ed. 2022.
264 1 _aCham :
_bSpringer International Publishing :
_bImprint: Springer,
_c2022.
300 _a1 online resource
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aPolypharmacy in cancer therapy -- Combined therapy for the treatment of cancer -- Importance of the infusion order in the treatment of cancer -- Chemotherapeutic protocols for the treatment of breast cancer -- Chemotherapeutic protocols for the treatment of gastrointestinal tract cancer -- Chemotherapeutic protocols for the treatment of genitourinary cancer -- Chemotherapeutic protocols for the treatment of gynecological cancer -- Chemotherapeutic protocols for the treatment of head and neck cancer -- Chemotherapeutic protocols for the treatment of lung cancer -- Chemotherapeutic protocols for the treatment of neurological cancer.
520 _aThis book aims to address the infusion sequence of the main protocols used in the treatment of varied solid cancers. Since an inadequate infusion sequence can compromise the patient's treatment, this work will provide support to professionals working in the field of oncology in assessing each chemotherapy infusion sequence. The introductory chapters present the definition, indication, and the risks and benefits of polypharmacy in cancer therapy, and discuss the importance of drug combination in cancer treatment. Chapter 2 focuses on the challenges and also the toxicity of combination therapy in cancer, while chapter 3 highlights the parameters that must be evaluated before defining the infusion sequence, such as pharmacodynamic and pharmacokinetic profiles, drugs’ stability when diluted or reconstituted, toxicological profile of each drug, among others. The remaining chapters are divided by type of cancer. The content is focused on solid tumors, dividing the chapters according to breast, gastrointestinal, genitourinary, gynecological, head and neck, lung, and neurological cancers. In each chapter the epidemiological profiles, pathophysiology, therapeutic modalities, and the main chemotherapy protocols are addressed, as well as efficacy studies and data on the infusion sequence of each mentioned protocol. This work will be a valuable resource to physicians, nurses, and pharmacists, and may help to improve health service practices.
650 0 _aOncology.
650 0 _aPharmacology.
650 1 4 _aOncology.
650 2 4 _aPharmacology.
710 2 _aSpringerLink (Online service)
856 4 0 _uhttps://doi.org/10.1007/978-3-031-10839-6
_3Springer eBooks
_zOnline access link to the resource
942 _2NLM
_cEBK
041 _aeng